November 18, 2024
Richard Manning provided trial testimony that contributed to a decisive legal victory for biotech startup Inhibrx in a $460 million trade secrets case brought by I-Mab Biopharma in Delaware federal district court.
Secretariat was engaged by law firms Potter Anderson and Wilson Sonsini to provide expert testimony and respond to Plaintiff’s damages claims for this case on behalf of their clients, Inhibrx Biosciences and Inhibrix co-founder Dr. Brendan Eckelman.
On November 1, 2024, a federal jury in the US District Court for the District of Delaware unanimously sided with Inhibrx, rejecting all allegations of misappropriation and finding that the data in question did not qualify as legally-protectable trade secrets.
“I am pleased that my testimony was accepted by the court and helped the jury reach a verdict,” said Dr. Manning. “I trust that my economic analysis, combined with my prior experience in the biopharmaceutical industry, helped the jury understand the facts of this complex, high-stakes case.”
I-Mab filed the lawsuit on March 1, 2022, claiming that Inhibrx and Dr. Eckleman misappropriated confidential information related to I-Mab research projects during prior arbitration proceedings involving I-Mab, for which Dr. Eckelman had served as an expert witness. The Delaware jury found no basis for these claims and awarded the plaintiff $0 in damages, based in part on Dr. Manning’s testimony. The jury’s findings marked a complete victory for Inhibrx and Dr. Eckelman.
Read more about this case on Law360 (subscription required).
Why Funder Forecasts Don’t Belong in Royalty Analysis
This article originally appeared on Law360 on June 24, 2025. In a recent article published by Law360, Managing Director Rick Eichmann explores the economic reasoning behind the U.S. District Court’s decision in Haptic Inc. v. Apple Inc. and why prelitigation funding forecasts should not be conflated with royalty analyses in patent litigation. Eichmann explains how models developed for […]
SFO’s ‘Cast-Iron Guarantee’ on Self-Reporting Comes With Fine Print
Ben Boorer, writing for Corporate Compliance Insights, examines the UK Serious Fraud Office’s clearest commitment yet to corporate self-reporting, offering a “cast-iron guarantee” of DPA negotiations for companies that self-report and cooperate. The guidance sets out defined timelines intended to bring greater predictability, but uncertainties remain around how much investigation is expected before reporting, what […]
Strengthening Export Control Compliance: Advanced Strategies for Third-Party Audits
This article first appeared on Law360 on July 7, 2025. In a recent Law360 article, Michael H. Huneke of Hughes Hubbard & Reed and John Rademacher and Abby Williams of Secretariat explore advanced strategies for strengthening export control compliance through improved third-party audits. U.S. technologies continue to be diverted to foreign adversaries, often through networks of resellers […]